Stock TBPH THERAVANCE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Theravance Biopharma, Inc.

Equities

TBPH

KYG8807B1068

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
9.46 USD +0.96% Intraday chart for Theravance Biopharma, Inc. +3.73% -15.84%
Apr. 12 Sector Update: Health Care Stocks Lower Friday Afternoon MT
Apr. 12 Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Lower Friday Afternoon
Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy
Theravance Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Theravance Biopharma Shares Drop Pre-Bell as Phase 4 Study of Lung Disease Treatment Fails to Meet Primary Endpoint
Top Premarket Decliners
Theravance Biopharma Announces Results from the Phase 4 YUPELRI®? PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease
Theravance Biopharma, Inc. Appoints Jeremy Grant as Independent Director
Viatris, Theravance Biopharma Say Trial in China Shows Efficacy, Safety of COPD Treatment
Theravance Biopharma, Inc. Announces Board Changes
Theravance Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders
Theravance Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Theravance Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Weiss Asset Management Engages with Theravance Biopharma
Irenic Capital Provides Information to Shareholders of Theravance Biopharma
Theravance Biopharma, Inc. Announces Appointment of Jim Kelly to Board of Directors
Theravance Biopharma, Inc. Announces Independent Director, Bill Young, Will Not Be Standing for Reelection to the Board of Directors
Theravance Biopharma Provides Information to Shareholders
Theravance Biopharma, Inc. Announces Board Changes
Theravance Biopharma, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBPH Stock
  4. News Theravance Biopharma, Inc.
  5. Other languages